跳至主要内容
临床试验/JPRN-jRCT2080221502
JPRN-jRCT2080221502未知3 期

A clinical study of KRN125 compared to KRN8601 for chemotherapy-induced neutropenia in elderly patients with non-Hodgkin's lymphoma

Kyowa Hakko Kirin Co., Ltd.0 个研究点开始时间: 2011年6月30日最近更新:

试验速览

阶段
3 期
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 65age old 至 ot applicable(—)
性别
All

入选标准

  • Written informed consent
  • - Diagnosed with non-Hodgkin's lymphoma
  • - Going to receive (R) CHOP treatment regimen
  • - No prior chemotherapy
  • - ECOG PS =< 2
  • - Appropriate bone marrow, hepatic, renal and heart functions

排除标准

  • - Complication or anamnesis of cardiac disease, such as heart
  • failure and severe arrhythmia
  • - Double cancer
  • - Previous bone marrow or peripheral blood stem cell
  • transplantation
  • - Primary hematologic disease such as myelodysplastic
  • syndrome or aplastic anemia
  • - Undergoing interstitial pneumonia treatment
  • - Previous radiotherapy within 4 weeks of enrollment

研究者

发起方
Kyowa Hakko Kirin Co., Ltd.

相似试验

A phase III, clinical study of KRN125 | 临床试验